Effective gravitational action for 2D massive fermions

We work out the effective gravitational action for 2D massive Euclidean fermions in a small mass expansion. Besides the leading Liouville action, the order m2 gravitational action contains a piece characteristic of the Mabuchi action, much as for 2D massive scalars, but also several non-local terms involving the Green’s functions and Green’s functions at coinciding points on the manifold.

A New Optimization Algorithm Based on the Fungi Kingdom Expansion Behavior for Antenna Applications

This paper presents a new optimization algorithm based on the behavior of the fungi kingdom expansion (FKE) to optimize the radiation pattern of the array antenna. The immobile mass expansion of the fungi is mimicked in this work as a chaotic behavior with a sinusoidal map function, while the mobile mass expansion is realized by a linear function. In addition, the random germination of the spores is utilized for randomly distributing the variables that are far away from the best solution. The proposed FKE algorithm is applied to optimize the radiation pattern of the antenna array, and then its performance is compared with that of some well-known algorithms. The MATLAB simulation results verify the superiority of the proposed algorithm in solving 20-element antenna array problems such as sidelobe reduction with sidelobe ratio (SLR = 25.6 dB), flat-top pattern with SLR = 23.5 dB, rectangular pattern with SLR = 19 dB, and anti-jamming systems. The algorithm also results in a 100% success rate for all of the mentioned antenna array problems.

β-Arrestin-1 is required for adaptive β-cell mass expansion during obesity

Obesity is the key driver of peripheral insulin resistance, one of the key features of type 2 diabetes (T2D). In insulin-resistant individuals, the expansion of beta-cell mass is able to delay or even prevent the onset of overt T2D. Here, we report that beta-arrestin-1 (barr1), an intracellular protein known to regulate signaling through G protein-coupled receptors, is essential for beta-cell replication and function in insulin-resistant mice maintained on an obesogenic diet. Specifically, insulin-resistant beta-cell-specific barr1 knockout mice display marked reductions in beta-cell mass and the rate of beta-cell proliferation, associated with pronounced impairments in glucose homeostasis. Mechanistic studies suggest that the observed metabolic deficits are due to reduced Pdx1 expression levels caused by beta-cell barr1 deficiency. These findings indicate that strategies aimed at enhancing barr1 activity and/or expression in beta-cells may prove useful to restore proper glucose homeostasis in T2D.

STrEAMlining EFT Matching

This paper presents STrEAM (SuperTrace Evaluation Automated for Matching), a Mathematica package that calculates all functional supertraces which arise when matching a generic UV model onto a relativistic Effective Field Theory (EFT) at one loop and to arbitrary order in the heavy mass expansion. STrEAM implements the covariant derivative expansion to automate the most tedious step of the streamlined functional matching prescription presented in Ref. [1]. The code and an example notebook are available at this link.

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature

Background Polycythemia vera (PV) is characterized by red cell mass expansion in the peripheral blood and can be complicated with thrombosis, bleeding, evolution to acute myeloid leukemia (AML) or a fibrotic phase. Paroxysmal nocturnal hemoglobinuria (PNH) in an acquired clonal haematopoietic stem cell disorder associated with chronic intravascular hemolysis, venous thrombosis, defective hematopoiesis, frequent episodes of infection and, rarely, leukemic transformation. Herein, we report an interesting case of a patient with coexistence of PNH clones and a JAK2V617F positive PV, with unusual thromboses without hemolysis. Case presentation A 51-year-old woman presented with increased levels of hematocrit, multiple liver, spleen, and left kidney infarctions and ascites; further investigation revealed a JAK2V617F-positive polycythemia vera and the presence of a significant PNH population (more than 90% CD55– CD59– cells among both granulocytes and red blood cells). Interestingly, the patient has experienced severe thrombotic events without any signs or symptoms of hemolysis. Conclusions This case raises questions over uncharted aspects of the PNH etiopathogenesis and its potential association with myeloproliferative neoplasms (MPN) and highlights the difficulty of diagnosing and managing patients with more than one potentially thrombophilic conditions, especially with established and severe thromboses.

Targeting islet G-protein-coupled receptors for type 2 diabetes therapy

The majority of people with diabetes have type 2 diabetes (T2D), where hyperglycaemia occurs because the islet β-cells are unable to secrete enough insulin, usually in the context of insulin resistance that arises because of fat mass expansion. There are a range of pharmacotherapies in current use to treat T2D and pharmaceutical companies are actively engaged in the development of novel therapies for better glucose control. Ligands that target G-protein-coupled receptors (GPCRs) are obvious candidates because they are used successfully for a wide range of disorders and GLP-1 receptor agonists, which are a relatively recent class of diabetes therapy, have proved to be very effective in treating T2D. We provide here an overview of current successes, some drawbacks and future possibilities for GPCR-based T2D therapies.